Arkolith/Insider Trading/FBRX/Form 4

Wagner Paul A.

SEE REMARKS, DirectorForte Biosciences, Inc. (FBRX) · full profile →Form 4 · filed Jan 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 1, 2025Tax withholding(F)164$22.71$4K79K
Jan 1, 2025Option exercise(M)1K—$079K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 1, 2025Option exercise(M)1K—$010K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-000141) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML